“ST Pharm provides reliable and timely custom manufacturing services for API following stringent quality system and close communication with the clients.”
Founded in 1983, ST Pharm (formerly known as Samchully Pharmaceutical) has been offering excellent custom manufacturing services of APIs and their intermediates to meet clients’ high expectation for their use in pharmaceutical development in compliant to cGMP requirements. Our reliability in service, which is well-proven through decades of business relationship with many big pharmas and biotech clients, is the essence of our strength along with our expertise in process development and scale-up optimization.
Historically, ST Pharm has been focusing our expertise on nucleoside based active pharmaceuticals in various antiviral drug applications; we became the world largest supplier of Thymidine in the late 1990s and Zidovudine in the mid 2000s and protected nucleosides in the early 2000s. ST Pharm has continuously been expanding its service offering, including synthesis of therapeutic oligonucleotides.
In June 2010, ST Pharm became a subsidiary of Dong-A Pharmaceutical, the top pharmaceutical company in Korea.
ST Pharm is committed to expanding its business scope into generic APIs and their intermediates with full support and collaboration with parent company Dong-A Pharmaceutical.
Company Details
- Employees
- 136
- Founded
- -
- Address
- 520, Yeongdong-Daero, Gangnam-Gu, 7f,korea, Republic Of
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.stpharm.co.kr/en
- Keywords
- New Drug APIs & Intermediates (Anti HCV/HIV/AIDS), Generic APIs & Intermediates (Anti-Viral Cancer Coagulant hypertensive), Oligonucleotides & Amidites & Nucleoside Monomers (Anti-Cancer), and mRNA CDMO (5'-cap, LNP).
- HQ
- Seoul
St Pharm Questions
St Pharm's website is https://www.stpharm.co.kr/en
St Pharm's LinkedIn profile is https://www.linkedin.com/company/stpharm
St Pharm has
136 employees.
View email and phone details for 136
employees at St Pharm.
St Pharm's industry is
Pharmaceutical Manufacturing
St Pharm's top competitors are
Chong Kun Dang Pharm.,
Dong-A Pharmaceutical Co.,ltd,
Yuhan Corporation,
Lotte Biologics,
Daewoong Pharmaceutical,
Samsung Biologics,
Stgen Bio,
Hanmi Pharmaceuticals,
Gc Biopharma (Gc녹십자),
Quantoom Biosciences.
St Pharm's categories are Pharmaceutical Manufacturing
St Pharm's founding year is 1983
